What is the most common site of a glucagonoma (glucagon-producing tumor) in the pancreas?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Most Common Site of Glucagonoma

Glucagonomas most commonly occur in the body and tail of the pancreas, making option D (Body and tail) the correct answer. 1, 2

Anatomical Distribution

The National Comprehensive Cancer Network guidelines specifically identify the tail of the pancreas as the most common site for glucagonomas, which is why distal pancreatectomy with splenectomy is the standard surgical approach for these tumors. 1

Supporting Evidence from Multiple Sources:

  • Research studies consistently confirm this distribution: Most glucagonomas are solid tumors that arise in the body or tail of the pancreas. 2

  • Case reports demonstrate tail predominance: A documented case of a 70-year-old patient had an alpha-cell tumor located specifically in the tail of the pancreas. 3

  • Contrast with ductal adenocarcinoma: This distribution pattern is distinctly different from ductal adenocarcinoma of the pancreas, where 80-90% occur in the head of the gland. 4, 1 This anatomical difference is clinically important for differential diagnosis.

Clinical Implications of Location

Surgical Approach Based on Location:

  • For tail location (most common): The National Comprehensive Cancer Network recommends distal pancreatectomy with splenectomy and resection of peripancreatic lymph nodes. 1

  • For head location (less common): When glucagonomas do occur in the pancreatic head, pancreatoduodenectomy (Whipple procedure) with peripancreatic lymph node resection is required. 1

  • Small peripheral tumors (<2 cm): Enucleation or local excision with peripancreatic lymph dissection may be considered. 1

Important Caveat:

One retrospective study of 12 patients found that 50% had tumors located in the head of the pancreas, which contradicts the general consensus. 5 However, this single study's findings are outweighed by multiple other sources and guideline recommendations that consistently identify the body and tail as the predominant location. 1, 3, 2

Key Clinical Pearls:

  • Splenectomy is mandatory for glucagonomas due to their typically malignant nature with regional lymph node involvement, unlike other pancreatic neuroendocrine tumors where spleen preservation may be attempted. 6

  • Perioperative anticoagulation should be considered due to the hypercoagulable state associated with glucagonoma syndrome and increased risk of thromboembolism. 1, 6

References

Guideline

Management of Glucagonoma

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Cystic glucagonoma: A rare variant of an uncommon neuroendocrine pancreas tumor.

Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, 1998

Research

Glucagonoma syndrome: a case report.

Journal of medical case reports, 2011

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Is glucagonoma of the pancreas a curable disease?

International journal of pancreatology : official journal of the International Association of Pancreatology, 2001

Guideline

Spleen-Preserving Distal Pancreatectomy for Benign or Low-Grade Malignant Tumors

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.